Literature DB >> 3432603

The depressor effect of secretin administered either centrally or peripherally in conscious rats.

R Hashimoto1, F Kimura.   

Abstract

The role of secretin in systemic blood pressure was examined in conscious rats. Either i.c.v. (0.5 or 1.0 micrograms/2 microliter 0.9% saline) or i.v. (1.0 or 2.0 micrograms/10 or 25 microliter saline) administration of secretin in conscious rats resulted in a significant fall in blood pressure. In consideration of previous findings that many other peptides such as substance P, enkephalin, bradykinin, neurotensin and vasoactive intestinal polypeptide cause pressor effects when administered centrally, but produce depressor responses after peripheral administration, the hypotension induced as both central and peripheral effects of secretin is unique and significant.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3432603     DOI: 10.1016/0167-0115(87)90279-5

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  2 in total

Review 1.  Secretin: Should we revisit its metabolic outcomes?

Authors:  D H St-Pierre; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

2.  Loss of secretin results in systemic and pulmonary hypertension with cardiopulmonary pathologies in mice.

Authors:  Aung Moe Zaw; Revathi Sekar; Sarah O K Mak; Helen K W Law; Billy K C Chow
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.